Gene Query: MAPRE3

Dataset Description Geneva Score
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 31.89
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 21.04
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 20.63
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 20.63
Rorc disruption in human FG pancreatic cancer cells 17.6
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 16.04
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 15.46
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 15.13
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 14.78
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 14.42
Examining serotonergic neuron differentiation from human iPSCs 14.3
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 13.17
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 12.56
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 12.4
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 12.39
nELAVL HITS-CLIP in Alzheimer's Disease patients 12.03
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 11.96
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 11.94
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 11.94
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 11.48
TGF-β promotes genomic instability after loss of RUNX3 11.42
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 11.14
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 11.02
A549 cells and MSR-A549 cells 10.86
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 10.86
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 10.36
Transcriptome analysis of human lung epithelial cells 10.07
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 9.83
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 9.71
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 9.71
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 9.64
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 9.56
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 9.56
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 8.95
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 8.94
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 8.92
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 8.91
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 8.67
Transcriptional profiling of LS1034 cells treated with tepoxalin 8.61
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 8.57
Genome-wide functional assessment of enhancer activities in the human genome 8.52
AUF-1 affected genes in human skin cells 8.35
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 8.12
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 8.1
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 8.09
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 8.09
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 8.06
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 7.98
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 7.9
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 7.83
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 7.76
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 7.71
U2AF1 mutations alter splice site recognition in hematological malignancies 7.64
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 7.4
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 7.4
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 7.29
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 7.26
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 7.26
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 7.24
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 7.22
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 7.2
Dtx3L and Androgen Signaling in Prostate Cancer 7.0
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 6.91
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 6.89
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 6.74
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 6.64
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 6.64
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 6.63
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 6.58
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 6.5
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 6.46
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 6.43
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 6.42
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 6.42
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 6.36
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 6.33
Analysis of transcriptional regulation by Myt1 and Myt1l 6.26
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.18
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 6.16
Control of prostate tumour growth by the long non-coding RNA GHSROS 6.15
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.11
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.11
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 5.99
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.98
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.98
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 5.81
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 5.53
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 5.51
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 5.51
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 5.48
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 5.46
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 5.41
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.4
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 5.38
circRNA-sequencing 5.38
SRSF2 mutations impair hematopoiesis and alter exon recognition 5.34
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 5.29
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 5.28
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.27
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 5.26
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 5.21
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.17
Gene expression profiling of human and murine in vitro muscle differentiation 5.14
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.94
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.94
Repurposing of promoters and enhancers during mammalian evolution 4.92
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 4.9
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 4.85
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 4.85
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.83
Identifying the molecular mode of action of itraconazole in colorectal cancer 4.82
Exploring ILF2 regulatory genes by next-generation sequencing 4.8
The Glioma-Infiltrating T Cell Receptor Repertoire 4.77
Engineering Patient-Specific Tissue Implants 4.75
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.75
FGF2 regulation of gene expression in stable inducible Neurons 4.69
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 4.68
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 4.65
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 4.65
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.65
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 4.65
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.58
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 4.55
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 4.53
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 4.48
RNA-seq of tumor cells following angiopellosis extravasation 4.46
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 4.43
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 4.42
FOXD3 is a novel tumor suppressor in lung cancer 4.41
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 4.39
Aneuploidy-induced cellular stresses limit autophagic degradation. 4.34
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 4.33
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 4.31
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 4.31
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 4.29
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 4.29
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 4.26
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 4.26
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 4.26
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.23
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 4.17
Epigenomic landscape during organ formation in human early embryos 4.17
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 4.16
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 4.12
The Human Testis Cell Atlas via Single-cell RNA-seq 4.06
KLF6-dependent transcription in renal cancer cells 4.04
Disruption of GRIN2B impairs differentiation in human neurons 4.02
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 4.01
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 4.01
Tumor exosome integrins determine organotropic metastasis 3.97
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 3.93
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 3.91
Transcriptional effect of ETV1 knockdown in melanoma cells 3.86
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 3.79
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 3.76
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.76
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 3.74
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 3.74
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 3.7
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 3.67
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 3.67
A549 cell transcriptome responses to infection with H7N9 influenza virus 3.67
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 3.66
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 3.66
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 3.65
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 3.62
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 3.61
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 3.61
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 3.59
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 3.59
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.57
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 3.46
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 3.44
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 3.41
Inhibition of TNBC metastasis by Gpx1 3.39
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.37
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 3.26
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.24
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 3.22
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 3.22
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.22
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.22
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 3.2
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 3.2
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 3.19
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.18
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.17
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 3.15
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 3.15
The pause-initiation limit restricts transcription activation in human cells 3.13
Comparing gene expression in iPSC derived RPE from control and AMD donors 3.08
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 3.08
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 3.03
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.03
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 3.01
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 3.01
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.01
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 3.0
TT-Seq captures the human transient transcriptome 2.96
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.95
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.95
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 2.93
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 2.93
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 2.91
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 2.91
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.91
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.9
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.9
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 2.89
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.87
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 2.85
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 2.84
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 2.84
Widespread regulated alternative splicing of single codons accelerates proteome evolution 2.84
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 2.83
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.78
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 2.78
The landscape of alternative splicing in aggressive prostate cancers 2.76
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 2.75
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.73
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.71
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.67
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.67
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 2.66
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 2.65
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 2.64
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 2.61
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.61
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.6
Characterization of human ILC2 subsets 2.6
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.6
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 2.59
The conserved transcriptional landscapes in human spermatogenesis 2.58
Effect of disulfiram treatment on pediatric high grade glioma 2.54
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.54
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 2.54
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 2.52
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.52
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 2.51
Dissecting neural differentiation regulatory networks through epigenetic footprinting 2.5
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.5
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.49
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 2.49
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.49
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.46
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 2.44
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.44
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 2.39
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 2.37
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 2.37
Chromatin landscape of human visceral and subcutaneous adipocytes 2.36
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.35
Role of FGFR1 in neuronal devlopment 2.33
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.33
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.33
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 2.32
CUREfast: Accelerating research with families 2.32
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 2.32
iPSC derived motor neuron cultures from C9ORF72 carriers 2.31
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 2.3
CHCHD2 gene KO effect in iPSC drived motor neurons 2.3
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.29
Characterization of parental and rociletinib-resistant derived H1975 cell lines 2.29
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 2.27
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.27
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.27
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 2.25
Transcriptome analyses of human pancreatic islets and pseudoislets 2.22
Alteration of the microRNA network during the progression of Alzheimer’s disease 2.22
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.22
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 2.22
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 2.2
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 2.18
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 2.18
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 2.18
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.17
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.17
MEIS1 regulates hematopoiesis in hPSCs 2.15
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 2.15
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 2.15
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 2.14
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 2.12
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.11
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.1
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 2.1
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.08
Total RNA sequencing of WT intestinal orgaonids. 2.06
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 2.05
Gene Expression Profiling of WT and KDM3A Knocked out Cell 2.05
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.05
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.05
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 2.05
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 2.04
miR941 overexpression experiment 2.04
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.02
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.0
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 1.98
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.97
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 1.97
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 1.97
CHCHD10 gene KO effect in iPSC drived motor neurons 1.96
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.95
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 1.94
ETV7 and interferon response 1.94
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 1.94
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.93
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 1.93
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.92
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.92
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.91
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.91
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 1.87
CSL 1.86
CSL RNA-Seq on HKC and SCC cell lines 1.86
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 1.84
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.84
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.82
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 1.81
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.8
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.8
Spliceosomal disruption of the non-canonical BAF complex in cancer 1.8
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.78
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 1.76
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 1.76
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.75
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.75
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.75
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.75
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.7
Trans-differentiation of human adult peripheral blood T cells into neurons 1.69
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.68
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.68
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.68
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.63
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.59
Impact on erythroid progenitor type on erythroid differntiation 1.59
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 1.55
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.54
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 1.49
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 1.47
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 1.44
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.43
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 1.43
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 1.43
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.42
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.41
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.41
RNA editing in nascent RNA affects pre-mRNA splicing 1.4
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 1.4
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 1.38
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.38
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 1.38
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 1.38
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.37
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 1.36
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 1.34
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 1.34
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 1.34
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.28
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 1.28
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.27
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.26
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.25
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.25
RNA seq with AML (NB4) cells upon FTO inhibition 1.22
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.21
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.21
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.21
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 1.2
RNA-Seq in PWS iPSC-derived neurons 1.19
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 1.18
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 1.17
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.17
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.14
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 1.14
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.14
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.12
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.12
K562 polyA RNA-Seq 1.11
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.11
RNAseq in Alzheimer's Disease patients 1.1
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.1
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.1
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.1
Zika virus directly infects human peripheral neurons and induces cell death 1.1
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.08
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.08
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 1.04
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 1.02
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.01
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.01
Identification of a LIF-responsive replication-competent human β cell 1.0
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.0
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.99
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.98
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.98
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.96
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 0.94
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 0.94
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.94
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.94
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.93
Effect of nuclear IL-33 on gene expression 0.84
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 0.82
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.81
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.8
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.8
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.79
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.78
RNA-seq of shEZH2 cells 0.78
Transcriptome sequencing of K-562 cells 0.74
The age and genomic integrity of neurons after cortical stroke in humans 0.72
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.72
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.71
RNA-Seq of the corpus callosum from 12 individuals 0.7
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.69
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.69
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 0.69
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.68
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 0.67
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 0.67
Multiple sclerosis and EAE 0.67
Human optic chiasm from healthy controls and multiple sclerosis patients 0.67
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.66
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.62
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 0.6
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 0.6
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.57
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.55
RNA-Seq and expression data from human adipose tissue 0.55
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.55
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.55
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.55
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.55
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.55
Total RNA sequencing of APC mutant and wt colonic organoids 0.55
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.53
Gene expression analysis upon mtDNA depletion 0.51
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.51
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.49
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.47
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.47
JAK dependent survival of ALK- ALCL 0.46
Finding missing proteins from epigenetically manipulated human cells 0.45
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.44
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.41
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.4
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.4
Gene expression analysis of human adenomas. 0.39
Gene expression analysis of human hepatocellular cancers 0.38
RNA Sequencing of Human iPS derived Cardiomyocytes 0.38
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.37
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 0.35
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 0.35
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 0.35
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.33
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.33
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.33
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.33
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.32
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.31
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.31
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.31
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.31
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.29
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.29
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.29
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.29
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.28
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.28
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.27
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.27
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.25
RNA-sequencing of healthy human skeletal myocytes 0.25
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.25
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.24
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.24
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.23
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.22
Co-regulation of splicing by Rbfox1 and hnRNP M 0.22
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 0.22
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.21
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.18
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.16
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.16
RNA seq analysis of human Fetal and adult derived Enterospheres 0.16
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.14
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.11
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.1
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.09
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.07
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.07
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.07
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.07
STX4 Over-Expression in Human islets 0.07
Deep RNA sequencing of the human placental transcriptome 0.06
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.05
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.01
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation